Our Website Uses Cookies
We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.
For more information, please contact us or consult our Privacy Notice.
Your binder contains too many pages, the maximum is 40.
We are unable to add this page to your binder, please try again later.
This page has been added to your binder.
- Home
- News and Insights
- Insights
- FDA Releases Draft Guidance on Responding to Unsolicited Requests for Off Label Information and Seeks Stakeholder Input on Scientific Exchange
FDA Releases Draft Guidance on Responding to Unsolicited Requests for Off-Label Information and Seeks Stakeholder Input on Scientific Exchange
January 9, 2012, Covington E-Alert
October 10, 2017, Covington Alert
This e-alert is part of a series of e-alerts summarizing publicly available FDA enforcement letters (i.e., warning letters and untitled letters) relating to the advertising and promotion of prescription drugs, medical devices, and biologics.
April 30, 2014, Covington E-Alert
August 10, 2012, Covington E-Alert